Medical devices

New technology and a changing focus is driving growth in the medtech sector.

The changing focus in healthcare from treatment to prevention and an increased user-centric approach is propelling medtech progress. The rapid uptake of technology using the capabilities of consumer devices and wearables, the application of big data and human-led innovation is fueling the wave of change.

Digital technology has entered all aspects of the industry, whether it is companies that specialise in AI and machine learning, robotics, telehealth and apps, or more traditional companies who must adapt and adopt such technologies to survive and thrive.

Medtech is a marketplace with unique challenges – global multinationals sit side-by-side with SMEs, universities and clinician-led innovation, resulting in a commercial playing field rich in collaboration. IP challenges are categorised by the complications of ownership in multi-party projects and the fast-changing case law around patenting in contentious areas such as medical methods, AI, data handling, software and commercialisation. HGF’s multidisciplinary teams are the ideal support in this evolving and complex sector.

 

Artificial limbs
Medical device

Our medical devices specialists

We’ve built our business by recruiting and developing specialists, not generalists. When it comes to protecting your ideas and business, you want to know you’re working with the best – people who truly understand your sector and the potential of your IP.

HGF’s team has medical devices professionals from an array of academic and business backgrounds. Our team-based approach ensures our clients benefit from the very best strategic advice from people who understand not only the legal environment but also the practical side of your business.

Let's talk

If you would like to discuss how HGF could help you, contact one of our medical devices specialists.

Latest news

HGF ranked band 1 in Chambers and Partners UK 2025

Chambers and Partners UK 2025 guide is now live. HGF is proud to be highly ranked as a firm and to have five ranked individuals. HGF is ranked band 1 …

Read article

The EPO Looks at the Morality and Patentability of Therapeutics Derived from Traditional Knowledge

This case (T2510/181) heard before the Technical Boards of Appeal at the EPO in May 2024 relates to the morality and novelty of substances of a natural origin. The invention …

Read article
Event - 7th November 2024

CIPSC Corporate IP Strategy Conference

HGF are proud to be platinum sponsors of the CIPSC event in Santa Clara, US. The CIPSC Unified Patents event will be held in Santa Clara, US on Thursday 7th …

Event details
Event - 7th November 2024

OUI Annual Networking Event

HGF are proud to be sponsoring the OUI Annual Networking Event in London on Thursday 7th November. This event will host key discussions around the impact of the Oxford’s Innovation …

Event details

Bite-sized MBA Course

HGF are proud to announce 14 of our colleagues have completed a bite-sized MBA and have now achieved a strategy consultation accreditation awarded from The University of East Anglia. The …

Read article
Event - 24th October 2024

CTA Demo Day

HGF is proud to be speaking at the Cancer Tech Accelerator Demo Day 2024. The Cancer Tech Accelerator Day 2024 will be held at HGF Limited, Leeds on Thursday 24th …

Event details